Azelaic Acid foam 15%

ApprovedCompleted
0 watching 0 views this week🔥 Hot
82
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
Phase 3
5
Approved
Indication / Disease

Rosacea, Papulopustular

Conditions

Rosacea, Papulopustular

Trial Timeline

Dec 6, 2017 → Jan 9, 2019

About Azelaic Acid foam 15%

Azelaic Acid foam 15% is a approved stage product being developed by Bayer for Rosacea, Papulopustular. The current trial status is completed. This product is registered under clinical trial identifier NCT03418610. Target conditions include Rosacea, Papulopustular.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (2)

NCT IDPhaseStatus
NCT03418610ApprovedCompleted
NCT01025635Phase 2Completed